{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:25:39Z","timestamp":1789050339508,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1193648"],"award-info":[{"award-number":["APP1193648"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 1176660"],"award-info":[{"award-number":["APP 1176660"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002337","name":"Petre Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ebiom.2022.104280","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T15:11:55Z","timestamp":1664205115000},"page":"104280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids"],"prefix":"10.1016","volume":"84","author":[{"given":"Jingya","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Kothur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Innes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velda X.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah F.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrujna","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Troedson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj P.","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Antony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ardern-Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Tantsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekeeb","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Wienholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda S.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8866-9838","authenticated-orcid":false,"given":"Anna","family":"Guller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Bandodkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-1826","authenticated-orcid":false,"given":"Russell C.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ebiom.2022.104280_bib0001","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(05)70199-X","article-title":"The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial","volume":"4","author":"Lux","year":"2005","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104280_bib0002","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1528-1167.2008.01688.x","article-title":"Risk of autism spectrum disorders after infantile spasms: a population-based study nested in a cohort with seizures in the first year of life","volume":"49","author":"Saemundsen","year":"2008","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104280_bib0003","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(16)30294-0","article-title":"Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial","volume":"16","author":"O'Callaghan","year":"2017","journal-title":"Lancet Neurol"},{"issue":"9447","key":"10.1016\/j.ebiom.2022.104280_bib0004","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(04)17400-X","article-title":"The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial","volume":"364","author":"Lux","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104280_bib0005","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2352-4642(18)30244-X","article-title":"Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial","volume":"2","author":"O'Callaghan","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104280_bib0006","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00004691-200311000-00004","article-title":"Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms\/West syndrome)","volume":"20","author":"Hrachovy","year":"2003","journal-title":"J Clin Neurophysiol"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104280_bib0007","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/ng.150","article-title":"De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy","volume":"40","author":"Saitsu","year":"2008","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104280_bib0008","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/426462","article-title":"Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation","volume":"75","author":"Weaving","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104280_bib0009","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1469-8749.2010.03746.x","article-title":"A possible association of responsiveness to adrenocorticotropic hormone with specific GRIN1 haplotypes in infantile spasms","volume":"52","author":"Ding","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ebiom.2022.104280_bib0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1824-7288-36-15","article-title":"Infantile spasms: review of the literature and personal experience","volume":"36","author":"Fois","year":"2010","journal-title":"Ital J Pediatr"},{"issue":"18","key":"10.1016\/j.ebiom.2022.104280_bib0011","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1093\/hmg\/ddu199","article-title":"The genetic landscape of infantile spasms","volume":"23","author":"Michaud","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104280_bib0012","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pediatrneurol.2011.08.010","article-title":"Genetic and biologic classification of infantile spasms","volume":"45","author":"Paciorkowski","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ebiom.2022.104280_bib0013","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0074-7742(02)49010-1","article-title":"Role of subcortical structures in the pathogenesis of infantile spasms: what are possible subcortical mediators?","volume":"49","author":"Lado","year":"2002","journal-title":"Int Rev Neurobiol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104280_bib0014","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.410310212","article-title":"Infantile spasms: II. Lenticular nuclei and brain stem activation on positron emission tomography","volume":"31","author":"Chugani","year":"1992","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104280_bib0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ana.410270408","article-title":"Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment","volume":"27","author":"Chugani","year":"1990","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104280_bib0016","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1212\/WNL.58.11.1646","article-title":"Focal and global cortical hypometabolism in patients with newly diagnosed infantile spasms","volume":"58","author":"Mets\u00e4honkala","year":"2002","journal-title":"Neurology"},{"issue":"Pt B","key":"10.1016\/j.ebiom.2022.104280_bib0017","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"issue":"19","key":"10.1016\/j.ebiom.2022.104280_bib0018","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1111\/bph.15534","article-title":"Altered hippocampal kynurenine pathway metabolism contributes to hyperexcitability in human mesial temporal lobe epilepsy-hippocampal sclerosis","volume":"178","author":"Dey","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2022.104280_bib0019","series-title":"Targeting the Broadly Pathogenic Kynurenine Pathway","first-page":"205","article-title":"Role of the kynurenine pathway in epilepsy","author":"Sharma","year":"2015"},{"key":"10.1016\/j.ebiom.2022.104280_bib0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2015.11.029","article-title":"Is the interaction between fatty acids and tryptophan responsible for the efficacy of a ketogenic diet in epilepsy? The new hypothesis of action","volume":"313","author":"Maciejak","year":"2016","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104280_bib0021","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1528-1167.2011.03103.x","article-title":"Clinical and histopathologic correlates of 11C-alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy","volume":"52","author":"Chugani","year":"2011","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104280_bib0022","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.0b013e3182a08f3f","article-title":"\u03b1-[11C]-Methyl-L-tryptophan\u2013PET in 191 patients with tuberous sclerosis complex","volume":"81","author":"Chugani","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104280_bib0023","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J Neurochem"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104280_bib0024","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104280_bib0025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1471-4159.2009.05893.x","article-title":"On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo","volume":"109","author":"Amori","year":"2009","journal-title":"J Neurochem"},{"issue":"6349","key":"10.1016\/j.ebiom.2022.104280_bib0026","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: Tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.104280_bib0027","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","article-title":"The kynurenine pathway and neurodegenerative disease","volume":"40","author":"Maddison","year":"2015","journal-title":"Semin Cell Dev Biol"},{"issue":"Pt B","key":"10.1016\/j.ebiom.2022.104280_bib0028","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104280_bib0029","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104280_bib0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0387-7604(95)00065-J","article-title":"Studies on cerebrospinal fluid kynurenic acid concentrations in epileptic children","volume":"17","author":"Yamamoto","year":"1995","journal-title":"Brain Dev"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104280_bib0031","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1528-1157.1994.tb02428.x","article-title":"Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures","volume":"35","author":"Heyes","year":"1994","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104280_bib0032","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1365-2265.1997.2991136.x","article-title":"Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures","volume":"47","author":"Mu\u00f1\u00f3z-Hoyos","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104280_bib0033","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0887-8994(91)90023-E","article-title":"Studies on CSF tryptophan metabolism in infantile spasms","volume":"7","author":"Yamamoto","year":"1991","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104280_bib0034","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0887-8994(94)90060-4","article-title":"Kynurenic acid is decreased in cerebrospinal fluid of patients with infantile spasms","volume":"10","author":"Yamamoto","year":"1994","journal-title":"Pediatr Neurol"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104280_bib0035","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1528-1167.2010.02695.x","article-title":"The underlying etiology of infantile spasms (West syndrome): Information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification2","volume":"51","author":"Osborne","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebiom.2022.104280_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.774828","article-title":"Etiologic classification of 541 infantile spasms cases: a cohort study","volume":"10","author":"Peng","year":"2022","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104280_bib0037","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebiom.2022.104280_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103917","article-title":"Development of a translational inflammation panel for the quantification of cerebrospinal fluid Pterin, Tryptophan-Kynurenine and Nitric oxide pathway metabolites","volume":"77","author":"Yan","year":"2022","journal-title":"eBioMedicine"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104280_bib0039","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/epi.16275","article-title":"Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus","volume":"60","author":"Kothur","year":"2019","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104280_bib0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol Rev"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104280_bib0041","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ntt.2011.07.002","article-title":"On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress","volume":"33","author":"Lugo-Huitr\u00f3n","year":"2011","journal-title":"Neurotoxicol Teratol"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104280_bib0042","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.bcp.2012.12.014","article-title":"Kynurenic acid as an antagonist of \u03b17 nicotinic acetylcholine receptors in the brain: facts and challenges","volume":"85","author":"Albuquerque","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"1-2","key":"10.1016\/j.ebiom.2022.104280_bib0043","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.ebiom.2022.104280_bib0044","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3389\/fpsyt.2018.00552","article-title":"The metabolic factor kynurenic acid of kynurenine pathway predicts major depressive disorder","volume":"9","author":"Liu","year":"2018","journal-title":"Front Psychiatry"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104280_bib0045","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3945\/jn.113.174599","article-title":"A mathematical model of tryptophan metabolism via the kynurenine pathway provides insights into the effects of vitamin B-6 deficiency, tryptophan loading, and induction of tryptophan 2,3-dioxygenase on tryptophan metabolites","volume":"143","author":"Rios-Avila","year":"2013","journal-title":"J Nutr"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104280_bib0046","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1158\/1055-9965.EPI-10-0407","article-title":"Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk","volume":"19","author":"Eussen","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ebiom.2022.104280_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103833","article-title":"Seizure modulation by the gut microbiota and tryptophan-kynurenine metabolism in an animal model of infantile spasms","volume":"76","author":"Mu","year":"2022","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104280_bib0048","first-page":"260","article-title":"Management of infantile spasms","volume":"4","author":"Nelson","year":"2015","journal-title":"Transl Pediatr"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104280_bib0049","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/epi4.12225","article-title":"Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group","volume":"3","author":"Kossoff","year":"2018","journal-title":"Epilepsia Open"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104280_bib0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ane.12830","article-title":"Efficacy of ketogenic diet for infantile spasms: a systematic review","volume":"137","author":"Prezioso","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104280_bib0051","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/epi.14679","article-title":"Efficacy and tolerability of the ketogenic diet versus high-dose adrenocorticotropic hormone for infantile spasms: A single-center parallel-cohort randomized controlled trial","volume":"60","author":"Dressler","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebiom.2022.104280_bib0052","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.seizure.2019.05.006","article-title":"Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy","volume":"69","author":"\u017barnowska","year":"2019","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104280_bib0053","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/adc.2009.160606","article-title":"Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial","volume":"95","author":"Darke","year":"2010","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ebiom.2022.104280_bib0054","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.eplepsyres.2014.11.012","article-title":"Neurodevelopmental outcome of infantile spasms: a systematic review and meta-analysis","volume":"109","author":"Widjaja","year":"2015","journal-title":"Epilepsy Res"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104280_bib0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.seizure.2014.05.010","article-title":"Predictive value of EEG findings at control of epileptic spasms for seizure relapse in patients with West syndrome","volume":"23","author":"Yamada","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.ebiom.2022.104280_bib0056","article-title":"Recent advances in clinical trials targeting the kynurenine pathway","volume":"236","author":"Pires","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104280_bib0057","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1038\/s41598-019-42646-4","article-title":"Kynurenic acid as the neglected ingredient of commercial baby formulas","volume":"9","author":"Milart","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104280_bib0058","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00726-008-0031-z","article-title":"Presence of kynurenic acid in food and honeybee products","volume":"36","author":"Turski","year":"2009","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104280_bib0059","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/JPN.JPN_51_17","article-title":"Amantadine for the treatment of refractory absence seizures in children","volume":"13","author":"Sreedharan","year":"2018","journal-title":"J Pediatr Neurosci"},{"key":"10.1016\/j.ebiom.2022.104280_bib0060","article-title":"A potential role for felbamate in TSC- and NF1-related epilepsy: a case report and review of the literature","volume":"2015","author":"Mishal","year":"2015","journal-title":"Case Rep Neurol Med"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104280_bib0061","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1586\/14737175.6.1.19","article-title":"Topiramate for the treatment of epilepsy and other nervous system disorders","volume":"6","author":"van Passel","year":"2006","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104280_bib0062","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1185\/146300905X75361","article-title":"Phenobarbital for childhood epilepsy: systematic review","volume":"7","author":"Pal","year":"2006","journal-title":"Paediatr Perinat Drug Ther"},{"issue":"s8","key":"10.1016\/j.ebiom.2022.104280_bib0063","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/epi.12027","article-title":"Current position of phenobarbital in epilepsy and its future","volume":"53","author":"Brodie","year":"2012","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104280_bib0064","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030464","article-title":"Ionotropic glutamate receptors in epilepsy: a review focusing on AMPA and NMDA receptors","volume":"10","author":"Hanada","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104280_bib0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/0972-2327.179971","article-title":"Evaluating the efficacy of memantine on improving cognitive functions in epileptic patients receiving anti-epileptic drugs: a double-blind placebo-controlled clinical trial (Phase IIIb pilot study)","volume":"19","author":"Marimuthu","year":"2016","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104280_bib0066","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0041-1739130","article-title":"Favorable Response to \u201cMemantine\u201d in a Child with GRIN2B Epileptic Encephalopathy","volume":"53","author":"Chidambaram","year":"2022","journal-title":"Neuropediatrics"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:35:33Z","timestamp":1778873733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422004625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":66,"alternative-id":["S2352396422004625"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104280","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104280"}}